Abivax is advancing obefazimod, a first-in-class oral therapy for UC and CD, with major upcoming data catalysts. Click here ...
McCormick & Company, Incorporated (NYSE:MKC) Q1 2026 Earnings Call Transcript March 31, 2026 McCormick & Company, Incorporated beats earnings expectations. Reported EPS is $0.66, expectations were $0.
In the topsy-turvy world of aviation, Willie Walsh, the sharpshooting incoming CEO of IndiGo, has a rather peculiar nickname: ...
Vishnu Kiritee Guttikonda ’26, a student in the Master of Advanced Management program, toured pharmaceutical and ...
Analyst/Investor Day March 31, 2026 12:00 PM EDTCompany ParticipantsAnoori Naughton - Vice President of Investor ...
Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 ...
ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 patients annually in ...
Vietnam Investment Review on MSN
Unisound revenue surges 30 in first post listing results
HONG KONG, March 27, 2026 /PRNewswire/ -- Unisound (09678.HK) announced its audited annual results for the year ended December 31, 2025. As the Company's first annual results announcement since ...
MetaOptics Ltd (Catalist: 9MT) (“MetaOptics” or the “Company”, and together with its subsidiaries, the “Group”) recently ...
Vietnam Investment Review on MSN
MetaOptics advances growth strategy and leadership transition
SINGAPORE, March 20, 2026 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") recently announced a series of strategic ...
For both the fourth quarter and full year 2025, the increases in R&D expenses were primarily due to higher clinical trial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results